Loading stock…

Enovis Corporation (ENOV) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Enovis Corporation

ENOVMarket cap $1.02BPrice $17.6

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Equipment

Makes reconstructive implants, braces, and surgical devices that help surgeons rebuild knees, shoulders, and spines. Split off from Colfax in 2022 to focus purely on medtech, betting big on ortho innovation while competing against giants like Stryker and Zimmer Biomet.

In Bastion Portfolios?

52W Return-44%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+13%8

Revenue Forecast

Rev CAGR (1y)+4%4

Rev CAGR (3y)+5%4

Rev CAGR (5y)+5%4

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2+1%4

EPS Growth Y+3+5%5

Quality

Margins

EBIT Margin4%2

Net Income Margin-48%1

Free Cash Flow Margin3%3

Debt

Net Debt/EBITDA3.43

Efficiency

ROE-54%1

ROA-25%1

Earnings Stability22

GEAR+VERY WEAK14

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)510

P/E Ratio (Forward 3y)410

P/BV0.710

EV Multiples

EV/EBITDA Fwd69

EV/EBIT Fwd89

Yield

Free Cash Flow Yield6.3%7

Dividend Yieldna–

Momentum

Short term

1 month return-12%2

3 month return-25%1

YTD return-34%1

Mid term

Price vs 52wHigh51%1

1 year return-45%1

Long term

3 year return-65%1

5 year return-79%1

Risk Shield

Price Risk

Beta1.42

Volatility64%2

Free Cash Flow

Free Cash Flow Margin3%3

Free Cash Flow Yield6.3%7

Quality

ROCE2%2

Earnings Stability22

Net Debt/EBITDA3.43

02Growth

Is it actually growing, and how fast?

ENOVEnovis

Revenue FY25$2.2B

GROWTH RATING↗

AVERAGE36 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+13%8

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+1%4

EPS growth, FY28E+5%5

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 13%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

WATCH

A mid-pack grower, ahead of 36% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 13%/yr over the last 3 years; forecasts see it cooling to 5%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK1 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-12%2

3-month return-25%1

YTD return-34%1

MID & LONG-TERM▾SCORE

% of 52-week high51%1

1-year return-45%1

3-year return-65%1

5-year return-79%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-65% over three years and -79% over five), behind 90% of the market.

It's down 45% over the past year, now 49% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-12%), over three months (-25%) and so far this year (-34%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Enovis Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ENOVEnovis

Revenue FY25$2.2B

GROWTH RATING↗

AVERAGE36 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+13%8

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+1%4

EPS growth, FY28E+5%5

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 13%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

WATCH

A mid-pack grower, ahead of 36% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 13%/yr over the last 3 years; forecasts see it cooling to 5%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK1 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-12%2

3-month return-25%1

YTD return-34%1

MID & LONG-TERM▾SCORE

% of 52-week high51%1

1-year return-45%1

3-year return-65%1

5-year return-79%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-65% over three years and -79% over five), behind 90% of the market.

It's down 45% over the past year, now 49% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-12%), over three months (-25%) and so far this year (-34%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Enovis Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community